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The effect of brain spectrin (fodrin) on actin has been studied using viscometry and fluorimetry. Brain 
spectrin resembles rythrocyte spectrin tetramer in its action on actin. Both proteins crosslink actin fila- 
ments giving rise to a large increase in the viscosity but fluorimetry shows that neither affects actin polymeri- 
zation significantly. In addition, brain spectrin as well as erythrocyte spectrin fragments preformed actin 
filaments. Actin filaments incubated in the presence of either of the two proteins incorporate actin 
monomers at a much higher rate showing that more filament ends are generated. 
Actin; Actin polymerization; Spectrin; Fodrin; Cytoskeleton; (Brain) 
1. INTRODUCTION 
The regulation of the rate and extent of actin 
polymerization as well as the organization of actin 
filaments into higher order structures are impor- 
tant processes for the function of eucaryotic cells. 
Specific actin-binding proteins seem to regulate ac- 
tin polymerization by, e.g. nucleation, binding to 
filament ends, fragmentation and crosslinking of 
filaments (review [l]). One interesting group of 
actin-binding proteins are the spectrins. These are 
proteins closely related to erythrocyte spectrin, the 
first discovered and most studied of this group. In 
erythrocytes, spectrin together with band 4.1 cross- 
link short actin filaments to build up a protein net- 
work, the cytoskeleton, closely associated with the 
plasma membrane. 
one another by varying the ionic conditions and 
temperature. Tetramer formation is favoured at 
high ionic strength. Either of the two forms can 
thereafter be trapped at low temperature because 
of the high activation energy [2]. 
Erythrocyte spectrin is a flexible rod-shaped 
molecule about 100 nm in length composed of an 
m-chain (240 kDa) and a B-chain (220 kDa). The 
heterodimers can self-associate head-to-head to 
form tetramers and higher oligomers. The dimer 
and tetramer are related by a thermodynamic 
equilibrium and can easily be interconverted into 
To date, spectrins have been isolated from a 
number of additional tissues [3-91. The best 
characterized forms are those found in the brain 
and intestinal brush border. All spectrins are flexi- 
ble rod-shaped molecules formed by self- 
association of heterodimers. In addition, to be 
considered as spectrin variants, they must be able 
to: (i) bind and gelate actin filaments; (ii) bind 
ankyrin; and (iii) bind calmodulin in a 
Ca’+-dependent manner. Brain spectrin, also 
called fodrin or calspectin, consists of two subunits 
of 240 and 235 kDa. It constitutes about 3% of the 
total membrane protein in brain [7]. Brain spectrin 
is not as easily dissociated into heterodimers as 
erythrocyte spectrin. The intestinal spectrin, 
TW 260/240, has subunits of 260 and 240 kDa as 
the name indicates [3]. The 240-kDa subunits (a- 
chain) of the three types of spectrin are similar ac- 
cording to antibody cross-reactivity whereas the & 
subunits are more variable 191. 
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volved in the attachment of actin filaments to the 
membrane. This idea is also supported by the 
discovery of an ankyrin analogue in brain [lo]. 
The binding to actin filaments also implies a func- 
tion in the control of cell shape and motility. As 
brain spectrin also associates with brain 
microtubules [ 1 I], it may function as a link be- 
tween those and actin filaments. Therefore it is of 
great interest o characterize further the interaction 
of spectrins with actin. This interaction is probably 
one of the most important functions of the spec- 
trins in the cell and has been the subject of several 
investigations [3,5,7,8,12-141. Bennett et al. [7] 
demonstrated, by high-speed centrifugation, that 
brain and erythrocyte spectrins co-sedimented with 
F-actin. Burns et al. [12] showed that brain spec- 
trin could exchange for erythrocyte spectrin in the 
formation of the ternary complex between spec- 
trin, actin and band 4.1. In another study, Sobue 
et al. [13] concluded, by viscosity measurements, 
that brain spectrin induces actin to polymerize, 
crosslinks actin filaments and decreases the critical 
concentration of actin. Their results show that the 
effects of brain spectrin on actin are much more 
pronounced than those of erythrocyte spectrin 
(15-17). 
The aim of this work was to characterize further 
the interaction of brain and erythrocyte spectrin 
with actin. Using both viscosity and fluorescence 
enhancement of pyrenyl-labelled actin for measur- 
ing polymerization it is shown~that both proteins 
bind to, crosslink, and fragment F-actin. The rate 
of polymerization and the critical concentration of 
actin are, however, affected to a lesser degree. 
While viscosity measurements can reflect both an 
increase in polymerization as well as crosslinking, 
fluorescence enhancement measures only the 
former. This difference between the two methods 
has also been noted in a recent study on the effects 
of actinogelin on actin [ 181. 
2. MATERIALS AND METHODS 
Actin and erythrocyte spectrin dimer were 
prepared as in [17]. Actin was labelled with N- 
(3-pyrenyl)maleimide as described in [19]. The 
degree of labelling of actin differed slightly be- 
tween different batches of pyrenylactin. For label- 
ling with [i4C]formaldehyde, actin was dialysed 
overnight against 0.1 M potassium phosphate buf- 
fer, 0.1 mM ATP, 0.2 mM CaC12, 0.5 mM 
2-mercaptoethanol, pH 7.0, to obtain F-actin. 
Thereafter [ “C]formaldehyde and NaBH3CN 
were added to the actin and incubation performed 
for 1 h at 25°C. The labelled F-actin was then 
sedimented by centrifugation for 1 h at 145000 x 
g, dissolved and dialysed against buffer A (see 
below). 
Erythrocyte spectrin dimer was converted to a 
mixture of about 50% dimer/50% tetramer by in- 
cubation in 150 mM KCl, 10 mM Tris-HCI, pH 
7.5, at 37°C for 2 h. This mixture is referred to as 
erythrocyte spectrin tetramer. 
Brain spectrin was prepared according to Ben- 
nett et al. [20] with some minor modifications. 
This yields about 90% pure brain spectrin, the con- 
taminants being polypeptides with M, close to 
150000. These polypeptides are degradation 
products of brain spectrin and their properties are 
very similar to those of the intact protein [20]. 
Actin was stored in 5 mM Tris-HCl, 0.2 mM 
ATP, 0.2 mM CaC12, 0.5 mM mercaptoethanol, 
pH 8.0 (buffer A). Erythrocyte spectrin was stored 
in 10 mM Tris-Cl, pH 7.5 (buffer S). Brain spec- 
trin was stored in 10 mM Tris-Cl, 0.4 mM DTT, 
0.01% Tween 20, pH 8.2 (buffer F). 
The viscosity measurements were performed in 
an Ubbelohde type viscometer with a buffer flow 
time of about 40 s. The fluorescence measure- 
ments were performed using a Perkin Elmer 512 
fluorescence spectrophotometer. The excitation 
and emission wavelengths were 366 and 405 nm, 
respectively (bandwidths 10 nm). The fluorescence 
intensity is expressed as a percentage of that of a 
5 PM fluorescein solution (excitation and emission 
wavelengths at 366 and 520 nm, respectively). 
All protein solutions were stored on ice and used 
within 10 days. The concentrations of actin, 
erythrocyte and brain spectrin were determined 
from the absorbance at 280 nm using absorptivity 
values of 1.1 [21], 1.07 [22] and 0.91 cm2.mg-’ 
[20], respectively. The concentrations of pyrenyl- 
actin and [i4C]actin were determined according to 
Bradford [23] using unlabelled G-actin as stan- 
dard. All measurements were made at 20°C. 
3. RESULTS AND DISCUSSION 
The results of the measurement of actin 
polymerization by viscometry in the presence of 
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Fig.1. (a) Actin pol~eri~at~~~ foliowed by viscometry in the absence (0) and presence (e) of brain spectrin. 400&l 
actin in buffer A was mixed with 1500 ~1 buffer F or brain spectrin in buffer F. After incubation for 15 min at 20°C 
polymerization was initiated by adding lOOpI KC1 in buffer A giving a final concentration of 100 mM. The final 
concentrations of actin and brain spectrin were 0.5 and 0.2 mg.ml-r, respectively. (b) Actin polymerization followed 
by viscometry in the absence (0) and presence of erythrocyte spectrin dimer (A) and tetramer (A). Actin in buffer A 
was mixed with an equaI volume of erythrocyte spectrin in buffer S. KCI was added to give the same final concentration, 
100 mM in all samples, and polymer~ation at 20°C was fohowed immediately after mixing. The finat ~n~~ntra~ons 
of both actin and erythrocyte spectrin were 0.5 mg.mi-‘. 
erythrocyte and brain spectrin are presented in 
fig. 1. Both brain spectrin and erythrocyte spectrin 
tetramer increase the viscosity of actin. 
Erythrocyte spectrin dimer, on the other hand, has 
a smaller, though significant effect. The observed 
increase in viscosity can be due to an induction of 
actin polymerization or a crosslinking of actin 
filaments by the spectrins, Earher results [lS,f7j 
obtained with pyrenyl-labelled actin showed that 
erythrocyte spectrin dimer has only a marginal ef- 
fect on the polymerization of actin. Enhancement 
of the fluorescence of pyrenyl-labelled actin, which 
gives a direct measure of the amount of F-actin, 
shows that brain spectrin does not induce a signifi- 
cant change in the rate of actin poIymeri~at~on 
(fig.2). Thus, the results are in accordance with 
those obtained with erythrocyte spectrin dimer 
[ 171. Since neither of the spectrins induces 
polymerization of actin the only explanation for 
the observed effect on viscosity, depicted in fig. 1) 
must be that the increase is due to crosshnking of 
the filamentous actin by brain and erythrocyte 
spectrin tetramer. On examining fig.lb one can 
also see that polymerization in the presence of 
spectrin dimer does not reach steady state as fast as 
actin alone or actin in the presence of spectrin 
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tetramer. This may reflect a continuous conversion 
of dimer to tetramer during the measurement. In 
the study of Ungewickell and Gratzer [Zj, about 
half of the spectrin is converted to tetramer within 
SO min at 29.5% and ionic conditions comparable 
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Fig.2. Actin polymerization followed by fluorescence 
enhancement of pyrenyl-labelled actin (5% of the actin 
was pyrenyl-labelled). Conditions same as in fig. la. (0) 
Actin alone, (e) actin and brain spectrin. 
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to those here. As this study is made at 20°C it is 
not possible to use their data to determine the ab- 
solute fraction of spectrin dimer converted to 
tetramer. The rate is obviously much slower at 
20°C but even small amounts of tetramer will 
probably have a noticeable effect on the viscosity 
due to crosslinking of actin filaments. 
The critical concentration of actin has been 
reported to be decreased by brain spectrin [ 131. 
This is in disagreement with the results obtained 
here by fluorescent measurements. The steady- 
state level of actin polymerization was not 
significantly altered by the presence of brain spec- 
trin (not shown). In addition, after incubation for 
20 h at 20°C under the same conditions as in fig.3, 
the amount of unsedimented [14C]actin after cen- 
trifugation at 240000 x g for 1 h was independent 
of the presence of brain spectrin. This again shows 
that viscometry is not a unique method for deter- 
mining the amount of F-actin when a crosslinking 
protein is present. 
A very interesting question was whether brain 
spectrin also fragments actin filaments as 
erythrocyte spectrin does, both by itself [17] and 
together with band 4.1 [15,17]. Therefore, the in- 
corporation of labelled actin monomers into 
unlabelled filaments was studied. Since the concen- 
tration of the added G-actin far exceeded the 
critical concentration, monomers were rapidly 
added to the free ends of existing actin filaments. 
Therefore, the rate of incorporation reflects the 
number of free filament ends in the sample. The 
results show (fig.3) that the rate of incorporation 
was considerably faster in the sample where actin 
had been incubated with brain spectrin. Thus, 
brain spectrin has an actin-fragmenting activity 
similar to that of erythrocyte spectrin. Brain spec- 
trin appears to be more active since more 
erythrocyte spectrin is needed to give the same 
fragmentation as brain spectrin (fig.3). This effect 
was confirmed by experiments at higher brain 
spectrin concentration where the effect was much 
larger and a concentration dependence similar to 
that of erythrocyte spectrin [17] could be seen. The 
effect must be due to fragmentation since if spec- 
trin acted only as a capping protein, there would 
probably be no increase in the rate of incorpora- 
tion of monomers. The concentration of actin 
monomers is certainly high enough to give incor- 
poration at both ends of the filament. If spectrin 
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Fig.3. Fragmenting activity of brain and erythrocyte 
spectrin on preformed actin filaments. 0.3 mgeml-’ 
unlabelled actin in buffer A was polymerized with 
100 mM KC1 for 24 h at 20°C and divided into 3 x 
100~1. To the first portion lOOr buffer F was added 
(o), to the second portion 100 ~1 of 0.2 mg . ml-’ brain 
spectrin in buffer F (A) and to the third portion 100 pl 
of 0.5 mg *ml-’ erythrocyte spectrin dimer (IX). After 
incubation for 10 min at 20°C the ability of the three 
samples to incorporate pyrenyl-labelled actin monomers 
was tested by adding 150 pl of the sample to 250 ~1 of 
0.5 mg 0 ml-’ pyrenyl-labelled G-actin. 
only caps one end without fragmenting the fila- 
ment the rate of incorporation would decrease 
rather than increase. Pinder et al. [15] concluded 
that erythrocyte spectrin and band 4.1 constitute a 
filament-severing and capping system. The results 
here indicate that brain spectrin is able to sever 
filaments but whether it also caps actin filaments 
is unclear since the critical concentration is not af- 
fected by its presence. 
In conclusion this study clearly demonstrates 
that brain and erythrocyte spectrin have similar ef- 
fects on actin polymerization. It shows that in ad- 
dition to the earlier known binding and gelation of 
actin, both proteins also have an actin fragmenting 
activity. Brain spectrin appears to be more active 
than erythrocyte spectrin in its action on actin. The 
strong effects of brain spectrin on actin 
polymerization shown by Sobue et al. [13] can 
most probably be attributed to the method used, 
i.e. viscometry. 
105 
Volume 213, number 1 FEBS LETTERS March 1987 
ACKNOWLEDGEMENTS 
I thank Drs Lars Backman and Vithaldas P. 
Shanbhag for valuable discussions during the ex- 
perimental work and for advice during the 
preparation of this paper. The skilful technical 
assistance of Miss Eleonore Granstrom and Mrs 
Eva-Maj Hagglof is also acknowledged. This work 
was partly financed by grants from O.E. and Edla 
Johanssons Scientific Foundation and the Swedish 
Natural Science Research Council (K-KU 
3602-l 10). 
REFERENCES 
PI 
PI 
[31 
141 
[51 
Fl 
171 
PI 
Korn, E.D. (1982) Physiol. Rev. 62, 672-737. 
Ungewickell, E. and Gratzer, W. (1978) Eur. J. 
Biochem. 88, 379-385. 
Glenney, J.R. jr, Glenney, P., Osborn, M. and 
Weber, K. (1982) Cell 28, 843-854. 
Glenney, J.R. jr, Glenney, P. and Weber, K. (1982) 
Proc. Natl. Acad. Sci. USA 79, 4002-4005. 
Glenney, J.R. jr, Glenney, P. and Weber, K. (1982) 
J. Biol. Chem. 257, 9781-9787. 
Bennett, V., Davis, J. and Fowler, W.E. (1982) 
Phil. Trans. Sot. Lond. B299, 301-312. 
Bennett, V., Davis, J. and Fowler, W.E. (1982) 
Nature 299, 126-131. 
Burridge, K., Kelly, T. and Mangeat, P. (1982) J. 
Cell Biol. 95, 478-486. 
[9] Glenney, J.R. jr and Glenney, P. (1984) Eur. J. 
1101 
IIll 
WI 
1131 
1141 
u51 
t161 
t171 
1181 
1191 
WI 
WI 
WI 
~231 
Biochem. 144, 529-539. 
Davis, J.Q. and Bennett, V. (1984) J. Biol. Chem. 
259, 13550-13559. 
Fach, B.L., Graham, SF. and Keates, R.A.B. 
(1984) Can. J. Biochem. Cell Biol. 63, 372-381. 
Burns, N.R., Ohanian, V. and Gratzer, W.B. 
(1983) FEBS Lett. 153, 165-168. 
Sobue, K., Kanda, K., Inui, M., Morimoto, K. and 
Kakiuchi, S. (1982) FEBS Lett. 148, 221-225. 
Davis, J. and Bennett, V. (1983) J. Biol. Chem. 
258, 7757-7766. 
Pinder, J.C., Ohanian, V. and Gratzer, W.B. 
(1984) FEBS Lett. 169, 161-164. 
Elbaum, D., Mimms, L.T. and Branton, D. (1984) 
Biochemistry 23, 4813-4816. 
Stromqvist, M., Backman, L. and Shanbhag, V.P. 
(1985) FEBS Lett. 190, 15-20. 
Ohtaki, T., Tsukita, S., Mimura, N., Tsukita, S. 
and Asano, A. (1985) Eur. J. Biochem. 153, 
609-620. 
Stromqvist, M., Backman, L. and Shanbhag, V.P. 
(1984) J. Muscle Res. Cell Mot. 5, 443-455. 
Bennett, V., Baines, A.J. and Davis, J. (1986) 
Methods Enzymol., in press. 
Elzinga, M., Collins, J.H., Kuehl, W.M. and 
Adelstein, R.S. (1973) Proc. Natl. Acad. Sci. USA 
70, 2687-2691. 
Kam, Z., Josephs, R., Eisenberg, H. and Gratzer, 
W.B. (1977) Biochemistry 16, 5568-5572. 
Bradford, M. (1976) Anal. Biochem. 72, 248-254. 
106 
